Log In
Print this Print this

Nav1.6 inhibitor

  Manage Alerts
Collapse Summary General Information
Company Xenon Pharmaceuticals Inc.
DescriptionNav1.6 (PN4; SCN8A) inhibitor
Molecular Target Nav1.6 (PN4) (SCN8A)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationEpilepsy
Indication DetailsTreat Dravet syndrome
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today